If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Trading Update

30 Sep 2014 07:00

RNS Number : 9598S
Royal Bank of Scotland Group PLC
30 September 2014
 



The Royal Bank of Scotland Group plc ("RBS")

 

Q3 2014 Trading Update and Presentation at Bank of America Merrill Lynch Banking & Insurance Conference

 

30 September 2014

 

Presentation at Bank of America Merrill Lynch Banking & Insurance Conference

 

Ross McEwan, RBS Chief Executive, will present at the Bank of America Merrill Lynch Banking & Insurance Conference in London on Tuesday 30 September 2014 at 9.30am (UK time). 

 

A live audio webcast and accompanying slides will be available on our website www.rbs.com/ir shortly before the presentation commences.

 

Q3 2014 Trading Update

 

RBS today provides an update on Q3 2014 financial performance.

 

· Q3 2014 has seen continued improvement in economic conditions and asset prices in our key markets, including Ireland. This has supported a further quarter of strong operating performance by RBS Capital Resolution ("RCR"). We anticipate that RCR will record net impairment provision releases in the region of £0.5bn in Q3 2014.

 

· RCR's future overall costs and speed of wind-down remain subject to significant potential volatility. The potential exists, if market conditions remain favourable, for RCR to incur limited future impairments and disposal losses, and an accelerated timetable to achieve its wind-down goals.

 

· Rising Irish residential property prices combined with pro-active debt management has resulted in lower arrears in Ulster (excluding RCR), within Personal & Business Banking. As a result we expect Ulster to record net provision releases in the region of £0.3bn in Q3 2014. The potential exists for further releases in future, if market conditions continue to improve.

 

· There has been an absence of large one-off impairments and lower levels of new non-performing loans in the rest of RBS's business during Q3 2014.

 

· RBS now expects to significantly outperform its previous guidance of c£1bn total impairments for FY 2014. Previously disclosed uncertainties remain, particularly relating to conduct and litigation matters.

 

· Corporate & Institutional Banking revenues have been weaker than anticipated in the third quarter.

 

· RBS took advantage of improved market prices to dispose of c€9bn legacy available for sale debt securities. These disposals generated a loss of around £0.2bn in Centre revenues. We expect these transactions to be moderately capital ratio accretive.

 

The figures quoted in this statement are preliminary estimates and unaudited. RBS will release its Q3 2014 Interim Management Statement on 31 October 2014.

 

 

For further information:

 

Investor Relations

Richard O'Connor

Head of Investor Relations

+44 (0) 20 7672 1758

 

Media Relations

+44 (0) 131 523 4205

 

If you would like a copy of this presentation in a different format (eg. large print, audio or Braille) please contact the Investor Relations team on +44 20 7672 1758 or investor.relations@rbs.com.

 

This release contains 'forward-looking statements' as that term is defined in the United States Private Securities Litigation Reform Act of 1995. Forward looking statements are statements that are not historical facts and can be identified by the use of forward-looking terminology such as statements that include the words 'expect', 'estimate', 'project', 'anticipate', 'believes', 'should', 'intend', 'plan', 'could', 'probability', 'risk', 'Value-at-Risk (VaR)', 'target', 'goal', 'objective', 'will', 'endeavour', 'outlook', 'optimistic', 'prospects' and similar expressions or variations on such expressions or by the forward looking nature of discussions of strategy, plans, targets and intentions. . These statements are based on current plans, estimates and projections, and are subject to inherent risks, uncertainties and other factors which could cause actual results to differ materially from the future results expressed or implied by such forward-looking statements. The forward-looking statements contained in this release speak only as of the date of this announcement, and the Group does not undertake to update any forward-looking statement to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. The information, statements and opinions contained in this document do not constitute a public offer under any applicable legislation or an offer to sell or solicitation of any offer to buy any securities or financial instruments or any advice or recommendation with respect to such securities or other financial instruments.

 

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQKKDPPBKKKCN
Date   Source Headline
30th Nov 20167:03 amRNSStatement re 2016 stress test results
22nd Nov 20163:35 pmRNSDividend Declaration
22nd Nov 20162:55 pmRNSPublication of Suppl.Prospcts
16th Nov 20166:00 pmRNSAllotment and Issue of New Ordinary Shares
9th Nov 20163:01 pmRNSDirector/PDMR Shareholding
8th Nov 20167:00 amRNSRBS Launches a New Complaints Process
31st Oct 20163:40 pmRNSTotal Voting Rights
28th Oct 20167:00 amRNSInterim Management Statement
6th Oct 20164:15 pmRNSBlock listing Interim Review
30th Sep 20161:37 pmRNSTotal Voting Rights
30th Sep 20167:00 amRNSProposed Future Ring Fenced Structure and Brands
28th Sep 20167:00 amRNSRBS Settles Certain RMBS Claims with the NCUA
27th Sep 20168:30 amRNSBank of America Merrill Lynch CEO Conference
12th Sep 20162:30 pmRNSBarclays Global Financial Services Conference
8th Sep 20167:00 amRNSRBSG priced $2.65 billion Senior Notes
2nd Sep 20165:44 pmRNSAllotment and Issue of new Ordinary shares
31st Aug 20162:43 pmRNSTotal Voting Rights
25th Aug 20167:02 amRNSDividend Declaration
25th Aug 20167:00 amRNSRedemption of USD Preference Shares Series R and T
23rd Aug 20163:00 pmRNSDirector/PDMR Shareholding
19th Aug 20162:15 pmRNSPublication of Suppl.Prospcts
11th Aug 20167:00 amRNSRBSG successfully priced $2.65bn Additional Tier
8th Aug 20163:30 pmRNSDirector/PDMR Shareholding
5th Aug 20167:00 amRNSHalf Year Report - Part 2
5th Aug 20167:00 amRNSHalf Year Report - Part 1
1st Aug 20167:07 amRNS2016 EBA EU-wide stress test results
29th Jul 20163:18 pmRNSTotal Voting Rights
21st Jul 20161:15 pmRNSVocaLink Holdings Limited Shareholding
30th Jun 20161:18 pmRNSTotal Voting Rights
29th Jun 20161:36 pmRNSHolding(s) in Company
27th Jun 20165:12 pmRNSDividend Declaration
24th Jun 201612:02 pmRNSPrice Monitoring Extension
9th Jun 20168:00 amRNSGoldman Sachs European Financials Conference
7th Jun 20165:30 pmRNSPublication of a Prospectus
1st Jun 20165:25 pmRNSNotification of Major Interest in Shares
31st May 20163:17 pmRNSTotal Voting Rights and Capital changes
26th May 20165:15 pmRNSDividend Declaration
24th May 20165:56 pmRNSAllotment and Issue of New Ordinary Shares
16th May 201610:00 amRNSAppointment of a Non-Executive Director
16th May 20167:07 amRNSNotices of Redemption
11th May 20163:39 pmRNSDirector/PDMR Shareholding
10th May 201612:40 pmRNSNotices of Redemption
4th May 20165:45 pmRNSResult of AGM
4th May 20161:55 pmRNSAGM Statement
29th Apr 20162:17 pmRNSTotal Voting Rights and Capital changes
29th Apr 20167:00 amRNSInterim Management Statement
28th Apr 20165:41 pmRNSRBS Holdings N.V. and Royal Bank of Scotland N.V.
28th Apr 20161:55 pmRNSUpdate on the disposal of Williams & Glyn
26th Apr 20164:04 pmRNSDividend Declaration
20th Apr 20163:03 pmRNSForm 8.3 - Electronic Data Processing plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.